Clinical Trials in Los Angeles

Showing 4121-4140 of 12,794 trials

Neonatal Pulse Oximetry Sensor Study

NCT05250102

To validate the SpO2 accuracy, bias, and precision of Medline's reprocessed pulse oximetry sensors as compared to SaO2 in arterial blood samples as assessed by CO-oximetry in neonates.

Premature Birth

Medline Industries23 participantsStarted Jun 2022

Los Angeles, California, United States • Greenville, North Carolina, United States

TERMINATEDPhase 2< 1 mile

A Study of TAK-994 in Adults With Type 1 and Type 2 Narcolepsy

NCT04096560

The main aims of the study are: * To check for side effects from TAK-994 and check what dose of TAK-994 participants can tolerate. * To check what dose range provides adequate relief of narcolepsy symptoms. * To check how much TAK-994 stays in the blood of participants, over time. The study will have 4 parts. Participants can only join 1 of the parts. A. Participants with type 1 narcolepsy will take either TAK-994 or placebo tablets for 28 days. A placebo looks just like TAK-994 but will not have any medicine in it. B. Participants with type 1 narcolepsy will take 1 of 3 doses of TAK-994 or placebo tablets for 56 days. C. Participants with type 1 narcolepsy in China only will take TAK-994 or placebo tablets for 56 days. D. Participants with type 2 narcolepsy will take either TAK-994 or placebo tablets for 28 days.

Narcolepsy Type 1 (NT1)Narcolepsy Type 2 (NT2)

Takeda97 participantsStarted May 2020

Alabaster, Alabama, United States • Phoenix, Arizona, United States • Bellflower, California, United States +75 more locations

Neonatal Pulse Oximetry Sensor Study

A Study of TAK-994 in Adults With Type 1 and Type 2 Narcolepsy

Find Trials by Condition in Los Angeles

Utility of Donor-Derived Cell Free DNA in Association With Gene Expression Profiling

A Study of LY3022855 In Participants With Breast or Prostate Cancer

ABC008 in Subjects with T-cell Large Granular Lymphocytic Leukemia (T-LGLL)

The PRISM Intervention for Adolescents and Young Adults Receiving Hematopoietic Cell Transplantation

Enhancing BodyWorks: a Canine Health Literacy Module

A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Cutaneous Lichen Planus

An Extension Study to Assess Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-4)

Evaluation of the RD-X19 Treatment Device in Individuals With Mild COVID-19

Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants

A Randomized, Open-label, Dose-ranging Study in Adults and Pediatric Individuals ≥ 12 Years of Age to Assess the Safety, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AZD7442, for Pre-exposure Prophylaxis of COVID-19

Can Single-Injection Adductor Canal Blocks Improve PostOp Pain Relief in Patients Undergoing Total Knee Arthroplasty?

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-experienced Adults (V116-006, STRIDE-6)

A Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia

A Study to Evaluate a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT)

Study of Novel Regimens in Relapsed or Refractory Multiple Myeloma

Study of BGB-290 or Placebo in Participants With Advanced or Inoperable Gastric Cancer

First-in-Human (FIH) Trial of GEN3009 in Subjects With Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas

Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms